Author

Claudia C Faria

Observed names: Claudia C. Faria, Claudia Faria

Institutions: University of Lisbon, Hospital de Santa Maria, Gulbenkian Institute for Molecular Medicine, Unidade Local de Saúde Santa Maria

Observed institutions: University of Lisbon, Hospital de Santa Maria, Gulbenkian Institute for Molecular Medicine, Unidade Local de Saúde Santa Maria

OpenAlex ID: A5125286343

MIF-CD74 signaling drives immune modulation in medulloblastoma

2026 · Benjamin Draper, Zhen You, et al. · Neuro-Oncology · 2

CCR2 is a potential biomarker and therapeutic target in Group 3 medulloblastoma

2026 · Carlos Custódia, Rita Cascão, et al. · bioRxiv (Cold Spring Harbor Laboratory)

The emerging role of chemokines and chemokine receptors in the biological and clinical behaviour of pituitary neuroendocrine tumours: An exploratory transcriptomic study

2026 · Ana Luísa Silva, Sayka Barry, et al. · Journal of Neuroendocrinology

MDB-14. Reshaping tumour immunity in MYC-driven medulloblastoma

2025 · Ben Draper, Dean Thompson, et al. · Neuro-Oncology Pediatrics

Works count: 4

Citation count: 2

H-index: 1

I10-index: